Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.

Ebner, Matthias; Birschmann, Ingvild; Peter, Andreas; Spencer, Charlotte; Härtig, Florian; Kuhn, Joachim; Blumenstock, Gunnar; Zuern, Christine S; Ziemann, Ulf; Poli, Sven

Ebner, Matthias; Birschmann, Ingvild; Peter, Andreas; Spencer, Charlotte; Härtig, Florian; Kuhn, Joachim; Blumenstock, Gunnar; Zuern, Christine S; Ziemann, Ulf; Poli, Sven.

Afiliación

Ebner M; Department of Neurology & Stroke, and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Birschmann I; Department of Internal Medicine and Cardiology, Charité University Medicine Berlin - Campus Virchow Klinikum, Berlin, Germany.
Peter A; Institute for Laboratory and Transfusion Medicine, Heart and Diabetes Center, Bad Oeynhausen, Ruhr University, Bochum, Germany.
Spencer C; Department of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany.
Härtig F; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
Kuhn J; German Center for Diabetes Research (DZD), Tübingen, Germany.
Blumenstock G; Department of Neurology & Stroke, and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Zuern CS; Department of Neurology & Stroke, and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Ziemann U; Institute for Laboratory and Transfusion Medicine, Heart and Diabetes Center, Bad Oeynhausen, Ruhr University, Bochum, Germany.
Poli S; Department of Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany.

Crit Care ; 21(1): 32, 2017 02 15.

Article en En | MEDLINE | ID: mdl-28196509

Asunto(s)

Anticoagulantes/análisis; Pruebas de Coagulación Sanguínea/normas; Tiempo de Tromboplastina Parcial/instrumentación; Sistemas de Atención de Punto/normas; Tiempo de Protrombina/instrumentación; Tiempo de Trombina/instrumentación; Anticoagulantes/farmacología; Anticoagulantes/uso terapéutico; Pruebas de Coagulación Sanguínea/métodos; Dabigatrán/análisis; Dabigatrán/uso terapéutico; Inhibidores del Factor Xa/análisis; Inhibidores del Factor Xa/uso terapéutico; Humanos; Tiempo de Tromboplastina Parcial/métodos; Estudios Prospectivos; Tiempo de Protrombina/métodos; Pirazoles/análisis; Pirazoles/uso terapéutico; Piridonas/análisis; Piridonas/uso terapéutico; Rivaroxabán/análisis; Rivaroxabán/uso terapéutico; Tiempo de Trombina/métodos

Palabras clave

Anticoagulation reversal; DOAC; Direct oral anticoagulants; Emergency surgery; NOAC; Non-vitamin K antagonist oral anticoagulants; POCT; Point-of-care testing; Stroke; Thrombolysis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tiempo de Tromboplastina Parcial / Tiempo de Protrombina / Tiempo de Trombina / Pruebas de Coagulación Sanguínea / Sistemas de Atención de Punto / Anticoagulantes Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Crit Care Año: 2017 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google